Follow us:


  • Home
  • News & informations

Ypso-Facto invests 1.4M€ in the development of a collaborative software suite for process design and evaluation

The company has received 800k€ from European Regional Development Fund (ERDF) to support the development of Ypso-Proxima®

  • by Ypso-Facto
  • January 14, 2021
Nancy, France, January 14th, 2021 - Ypso-Facto, a company specialized in the development and optimization of processes for the Life Sciences Industries invests 1.4M€, including € 800,000 from the European Regional Development Fund (ERDF), to support the development of its software suite Ypso-Proxima®...

Read more

NEW ARTICLE - Comparison of mAb single-use DSP processes by Sanofi using Ypso-Proxima

EASY: a disruptive mAb purification process to reduce cost of goods

  • by Ypso-Facto
  • January 08, 2021
This article [1] illustrates how Ypso-Proxima allows a rational comparison between two biopharmaceutical DSP processes. The innovative EASY mAb purification process developed by Sanofi is matched against the standard proteinA-based DSP counterpart. Relying on Proxima's process evaluation, the...

Read more

NEW ARTICLE – Fareva and Ypso-Facto investigate the purification of an antibiotic by ion-exchange

Using Mechanistic Modeling for Understanding Antibiotics Purification with Ion Exchange Chromatography

  • by Ypso-Facto
  • November 02, 2020
This article is based on a real industrial purification process by Fareva and highlights the power of mechanistic modeling for process development: Our client needed to change a raw material to secure his supply chain. From a process point of view, it was supposed to be seamless. However, a...

Read more

Indépendance sanitaire : La tribune de Roger-Marc Nicoud

“ Retrouver l’indépendance pour la production d’API : une chance pour les CDMO européennes ? "

  • by Ypso-Facto
  • May 13, 2020
La crise actuelle rappelle à l’Europe (et sans doute à l’Amérique du Nord) les limites de la délocalisation de la production. C’est le cas pour de nombreux produits, incluant bon nombre d’ingrédients pharmaceutiques actifs (API) et de médicaments en général. Cela ouvre la possibilité...

Read more

Feature article – Regaining independence in API production: A chance for European CDMOs

Roger-Marc Nicoud, CEO of Ypso-Facto, looks at the challenges and opportunities for CDMOs in the current crisis

  • by Ypso-Facto
  • May 12, 2020
The current crisis has highlighted the dependence of European and, indeed, North American countries on delocalised production. This is the case for many goods, including APIs and drugs in general. The opportunity is now there for European CDMOs to win additional business, but effort and adaptation...

Read more


Nancy (France), 25th March 2020

  • by Ypso-Facto
  • March 25, 2020
In this unprecedented situation, our number one priority is the safety and well-being of our people and those around us.  This is the reason why all our teams are working remotely. Please be assured that, while ensuring everyone’s health and safety, we remain focused on continued service to our...

Read more

Ypso-Facto, Your Process Secured and Optimized... it’s a Fact

Product Focus - Chimica Oggi - Chemistry Today customer’s publication

  • by Ypso-Facto
  • February 01, 2020
ABOUT YPSO-FACTO Ypso-Facto is a company helping industrial firms to develop, optimize and secure their chemical and bio-processes.  We commit to keeping our interests aligned with the ones of our customers. For this reason, we remain deliberately free from industrial property rights, production...

Read more

Digitalization for CDMOs: thinking outside the silos!

Panel discussion on custom synthesis and contract manufacturing, Chemistry Today, vol 37(4)

  • by Ypso-Facto
  • September 16, 2019
Marc-Olivier Simon and Moïse Bitton discuss the needs of CDMOs in terms of digitalization of their activities and the tools available on the market (ELN, LIMS, LES, SDMS, KM, QMS, MES etc.). While (Big) Pharmas have embraced digitalization, CDMOs seem far behind. The author see this as the result...

Read more

Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information